{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T04:11:55Z","timestamp":1794975115180,"version":"4.9.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T00:00:00Z","timestamp":1659052800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T00:00:00Z","timestamp":1659052800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Silver-coated megaprostheses are considered to reduce infection rate following reconstruction of bone defects in tumour surgery or revision arthroplasty. However, little is known about systemic silver exposure and possible side effects. The aim of this study was to analyse serum silver concentrations in patients with silver-coated megaprostheses over a prolonged time period. Between 2004 and 2016, 46 patients (52.2% female, mean age at surgery 47.1\u2009\u00b1\u200924.2\u00a0years) received silver-coated megaprostheses for septic (n\u2009=\u200926) or oncological (n\u2009=\u200917; main implant since 2013) indications, or aseptic loosening (n\u2009=\u20093). Blood was drawn from all patients within the first few days following surgery (without silver ion levels) and thereafter every 6\u00a0months at the outpatient department (with silver ion levels). Inductively coupled plasma mass spectrometry was used to determine silver ion levels. Median follow-up was 47.3\u00a0months (IQR: 16.1\u201378.9). Overall, 29 revision surgeries became necessary in 20 patients, equivalent to a cumulative complication rate of 63.0%. Revisions were most commonly for periprosthetic joint infections (PJIs, n\u2009=\u200912) and instability\/soft tissue problems (n\u2009=\u200910). Revision-free implant survival was 81.4%, 42.3% and 35.2% at one, 5 and 10\u00a0years. Incidence of local argyria was 8.7% (n\u2009=\u20094). Silver ion levels at two or more consecutive time points during follow-up were available for 26 patients. An increment of silver levels within the first months (\u201crun-in\u201d) was observed, followed by an unspecific undulating course. Median initial and latest follow-up (median, 49.5\u00a0months) serum silver ion levels were 16.0\u00a0ppb (IQR: 9.1\u201329.1) and 7.4\u00a0ppb (IQR: 2.7\u201314.1), respectively. According to the multivariate mixed linear random-effects model, development of PJI was associated with significantly higher silver ion levels over time (p\u2009=\u20090.002), irrespective of time from surgery (p\u2009=\u20090.274). In the current series, a cumulative complication rate of 63.0% was observed for patients receiving silver-coated megaprostheses for septic of oncological indications. An overall unspecific course of silver ion concentration was present. Development of PJI was significantly associated with increased silver ion levels over time. Yet, no systemic complication associated to high silver levels occurred. It can be concluded that silver-coated implants constitute a safe solution for megaprosthetic reconstruction, but monitoring of silver concentrations is recommended.<\/jats:p>","DOI":"10.1038\/s41598-022-16707-0","type":"journal-article","created":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T13:17:27Z","timestamp":1659100647000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Long-term changes in serum silver concentrations after extremity reconstruction with silver-coated megaprostheses"],"prefix":"10.1038","volume":"12","author":[{"given":"Maria Anna","family":"Smolle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko","family":"Bergovec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Scheipl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"G\u00f6ssler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Amerstorfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Glehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Leithner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Friesenbichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,29]]},"reference":[{"issue":"1","key":"16707_CR1","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1186\/s12891-017-1742-7","volume":"18","author":"D Zajonz","year":"2017","unstructured":"Zajonz, D. et al. Silver-coated modular Megaendoprostheses in salvage revision arthroplasty after periimplant infection with extensive bone loss\u2014a pilot study of 34 patients. BMC Musculoskelet. Disord. 18(1), 383 (2017).","journal-title":"BMC Musculoskelet. Disord."},{"issue":"6","key":"16707_CR2","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.arth.2007.06.015","volume":"23","author":"G Gosheger","year":"2008","unstructured":"Gosheger, G. et al. The influence of the alloy of megaprostheses on infection rate. J. Arthroplasty 23(6), 916\u2013920 (2008).","journal-title":"J. Arthroplasty"},{"issue":"18","key":"16707_CR3","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1016\/j.biomaterials.2007.02.033","volume":"28","author":"J Hardes","year":"2007","unstructured":"Hardes, J. et al. Lack of toxicological side-effects in silver-coated megaprostheses in humans. Biomaterials 28(18), 2869\u20132875 (2007).","journal-title":"Biomaterials"},{"issue":"3\u20134","key":"16707_CR4","first-page":"179","volume":"20","author":"E Sudmann","year":"1994","unstructured":"Sudmann, E. et al. Systemic and local silver accumulation after total hip replacement using silver-impregnated bone cement. Med. Prog. Technol. 20(3\u20134), 179\u2013184 (1994).","journal-title":"Med. Prog. Technol."},{"issue":"3","key":"16707_CR5","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1097\/01.ta.0000208126.22089.b6","volume":"60","author":"M Trop","year":"2006","unstructured":"Trop, M. et al. Silver-coated dressing acticoat caused raised liver enzymes and argyria-like symptoms in burn patient. J. Trauma 60(3), 648\u2013652 (2006).","journal-title":"J. Trauma"},{"issue":"2","key":"16707_CR6","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1302\/0301-620X.97B2.34554","volume":"97","author":"H Wafa","year":"2015","unstructured":"Wafa, H. et al. Retrospective evaluation of the incidence of early periprosthetic infection with silver-treated endoprostheses in high-risk patients: Case-control study. Bone Joint J. 97(2), 252\u2013257 (2015).","journal-title":"Bone Joint J."},{"issue":"1","key":"16707_CR7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00590-018-2270-3","volume":"29","author":"A Streitbuerger","year":"2019","unstructured":"Streitbuerger, A. et al. Silver-coated megaprostheses in the proximal femur in patients with sarcoma. Eur. J. Orthop. Surg. Traumatol. 29(1), 79\u201385 (2019).","journal-title":"Eur. J. Orthop. Surg. Traumatol."},{"issue":"24","key":"16707_CR8","doi-asserted-by":"publisher","first-page":"5547","DOI":"10.1016\/j.biomaterials.2004.01.008","volume":"25","author":"G Gosheger","year":"2004","unstructured":"Gosheger, G. et al. Silver-coated megaendoprostheses in a rabbit model\u2014An analysis of the infection rate and toxicological side effects. Biomaterials 25(24), 5547\u20135556 (2004).","journal-title":"Biomaterials"},{"issue":"7","key":"16707_CR9","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1302\/0301-620X.95B7.31124","volume":"95","author":"M Glehr","year":"2013","unstructured":"Glehr, M. et al. Argyria following the use of silver-coated megaprostheses: No association between the development of local argyria and elevated silver levels. Bone Joint J. 95(7), 988\u2013992 (2013).","journal-title":"Bone Joint J."},{"issue":"8","key":"16707_CR10","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.2106\/00004623-199508000-00003","volume":"77","author":"MM Malawer","year":"1995","unstructured":"Malawer, M. M. & Chou, L. B. Prosthetic survival and clinical results with use of large-segment replacements in the treatment of high-grade bone sarcomas. J. Bone Joint Surg. Am. 77(8), 1154\u20131165 (1995).","journal-title":"J. Bone Joint Surg. Am."},{"issue":"4","key":"16707_CR11","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s00590-017-1933-9","volume":"27","author":"T Schmidt-Braekling","year":"2017","unstructured":"Schmidt-Braekling, T. et al. Silver-coated megaprostheses: Review of the literature. Eur. J. Orthop. Surg. Traumatol. 27(4), 483\u2013489 (2017).","journal-title":"Eur. J. Orthop. Surg. Traumatol."},{"key":"16707_CR12","doi-asserted-by":"publisher","first-page":"9079041","DOI":"10.1155\/2016\/9079041","volume":"2016","author":"F Donati","year":"2016","unstructured":"Donati, F. et al. Silver-coated hip megaprosthesis in oncological limb savage surgery. Biomed. Res. Int. 2016, 9079041 (2016).","journal-title":"Biomed. Res. Int."},{"key":"16707_CR13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13037-016-0095-8","volume":"10","author":"D Zajonz","year":"2016","unstructured":"Zajonz, D. et al. Periprosthetic joint infections in modular endoprostheses of the lower extremities: A retrospective observational study in 101 patients. Patient Saf. Surg. 10, 6 (2016).","journal-title":"Patient Saf. Surg."},{"issue":"5","key":"16707_CR14","doi-asserted-by":"publisher","first-page":"238","DOI":"10.7150\/jbji.37757","volume":"4","author":"AME Jacobs","year":"2019","unstructured":"Jacobs, A. M. E., Valkering, L. J. J., Benard, M., Meis, J. F. & Goosen, J. H. M. Evaluation one year after DAIR treatment in 91 suspected early prosthetic joint infections in primary knee and hip arthroplasty. J. Bone Jt. Infect. 4(5), 238\u2013244 (2019).","journal-title":"J. Bone Jt. Infect."},{"issue":"9408","key":"16707_CR15","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/S0140-6736(04)15540-2","volume":"363","author":"NS Tomi","year":"2004","unstructured":"Tomi, N. S., Kranke, B. & Aberer, W. A silver man. Lancet 363(9408), 532 (2004).","journal-title":"Lancet"},{"key":"16707_CR16","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/978-3-211-98811-4_65","volume":"106","author":"HS Sharma","year":"2010","unstructured":"Sharma, H. S., Hussain, S., Schlager, J., Ali, S. F. & Sharma, A. Influence of nanoparticles on blood\u2013brain barrier permeability and brain edema formation in rats. Acta Neurochir. Suppl. 106, 359\u2013364 (2010).","journal-title":"Acta Neurochir. Suppl."},{"issue":"2","key":"16707_CR17","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00590-020-02779-z","volume":"31","author":"M Fiore","year":"2021","unstructured":"Fiore, M. et al. Silver-coated megaprosthesis in prevention and treatment of peri-prosthetic infections: A systematic review and meta-analysis about efficacy and toxicity in primary and revision surgery. Eur. J. Orthop. Surg. Traumatol. 31(2), 201\u2013220 (2021).","journal-title":"Eur. J. Orthop. Surg. Traumatol."},{"issue":"5","key":"16707_CR18","doi-asserted-by":"publisher","first-page":"418","DOI":"10.2106\/JBJS.J.00834","volume":"93","author":"ER Henderson","year":"2011","unstructured":"Henderson, E. R. et al. Failure mode classification for tumor endoprostheses: Retrospective review of five institutions and a literature review. J. Bone Joint Surg. Am. 93(5), 418\u2013429 (2011).","journal-title":"J. Bone Joint Surg. Am."},{"issue":"11","key":"16707_CR19","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1302\/0301-620X.96B11.34747","volume":"96","author":"ER Henderson","year":"2014","unstructured":"Henderson, E. R. et al. Classification of failure of limb salvage after reconstructive surgery for bone tumours: A modified system Including biological and expandable reconstructions. Bone Joint J. 96(11), 1436\u20131440 (2014).","journal-title":"Bone Joint J."},{"issue":"6","key":"16707_CR20","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.arth.2015.03.042","volume":"30","author":"BD Springer","year":"2015","unstructured":"Springer, B. D. The diagnosis of periprosthetic joint infection. J. Arthroplasty 30(6), 908\u2013911 (2015).","journal-title":"J. Arthroplasty"},{"key":"16707_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/9781119013563","volume-title":"Statistical Analysis with Missing Data","author":"RJA Little","year":"2002","unstructured":"Little, R. J. A. & Rubin, D. B. Statistical Analysis with Missing Data. 2nd edn. (Wiley, 2002).","edition":"2"},{"key":"16707_CR22","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.actbio.2017.05.048","volume":"58","author":"A Shivaram","year":"2017","unstructured":"Shivaram, A., Bose, S. & Bandyopadhyay, A. Understanding long-term silver release from surface modified porous titanium implants. Acta Biomater. 58, 550\u2013560 (2017).","journal-title":"Acta Biomater."},{"issue":"6","key":"16707_CR23","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/0002-9343(78)90446-1","volume":"64","author":"TT Ward","year":"1978","unstructured":"Ward, T. T. & Steigbigel, R. T. Acidosis of synovial fluid correlates with synovial fluid leukocytosis. Am. J. Med. 64(6), 933\u2013936 (1978).","journal-title":"Am. J. Med."},{"issue":"Suppl 4","key":"16707_CR24","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/j.injury.2016.07.042","volume":"47","author":"G Scoccianti","year":"2016","unstructured":"Scoccianti, G., Frenos, F., Beltrami, G., Campanacci, D. A. & Capanna, R. Levels of silver ions in body fluids and clinical results in silver-coated megaprostheses after tumour, trauma or failed arthroplasty. Injury 47(Suppl 4), S11\u2013S16 (2016).","journal-title":"Injury"},{"issue":"5","key":"16707_CR25","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/jso.21498","volume":"101","author":"J Hardes","year":"2010","unstructured":"Hardes, J. et al. Reduction of periprosthetic infection with silver-coated megaprostheses in patients with bone sarcoma. J. Surg. Oncol. 101(5), 389\u2013395 (2010).","journal-title":"J. Surg. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-16707-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-16707-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-16707-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T05:01:13Z","timestamp":1669352473000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-16707-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,29]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["16707"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-16707-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,29]]},"assertion":[{"value":"17 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13041"}}